4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-15-053913
VP, Pharma Dev & Manufacturing acquired 10,848 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kemmerer Christopher VP, Pharma Dev & Manufacturing | 2015-06-12 | Option exercise | +10,848 | $1.22 | $13,235 | 10,848 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kemmerer Christopher VP, Pharma Dev & Manufacturing | 2015-06-12 | Option exercise · Common Stock (Right to Buy) | −10,848 | 0 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…